BRIEF-Psivida submits marketing authorization application for approval of Durasert in EU
June 22, 2017 at 07:09 AM EDT
* Psivida submits marketing authorization application (maa) for approval of durasert™ three-year treatment for posterior segment uveitis in European Union
